- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Mesothelioma, Small Cell Lung Cancer, NSCLC in South Africa
Total 812 results
-
Cellxpert Biotechnology Corp.Medigen Biotechnology CorporationCompleted
-
AmgenCompletedNon Small Cell Lung CancerUnited States, Canada, Australia, Spain, Belgium, Greece
-
BioNTech SEActive, not recruitingSolid Tumor | Extensive-stage Small Cell Lung CancerUnited States, Spain, United Kingdom, Germany
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Lung Non-Small Cell Carcinoma | Stage IV Lung Non-Small Cell Cancer AJCC v7United States
-
Peregrine PharmaceuticalsCompletedCarcinoma, Non-Small-Cell Lung | Non-Small Cell Lung Cancer | Nonsmall Cell Lung Cancer | Non-Small-Cell Lung Carcinoma | Non-Small-Cell Lung Cancer Stage IIIB | Non-Small-Cell Lung Cancer Stage IV | Non-Small-Cell Lung Cancer MetastaticUnited States, Australia, Belgium, France, Germany, Greece, Hungary, Italy, Korea, Republic of, Romania, Russian Federation, Spain, Taiwan, Ukraine
-
Merck Sharp & Dohme LLCActive, not recruitingAdvanced Non-Small Cell Lung CancerPoland, Russian Federation, United States, Australia, Canada, Hong Kong, Ireland, Italy, Japan, Korea, Republic of, Singapore, South Africa, Spain, Switzerland, Taiwan, United Kingdom
-
Genor Biopharma Co., Ltd.RecruitingNSCLC | Other Solid TumorsAustralia
-
Novartis PharmaceuticalsTerminatedNon Small Cell Lung CancerSpain, Singapore, Germany, Switzerland, Australia, France, Italy, United States
-
Achieve Life SciencesCompletedNon-small Cell Lung CancerUnited States, Canada
-
NantCell, Inc.TerminatedAdvanced Squamous Non-Small Cell Lung CancerUnited States
-
NeoImmuneTechRoche Pharma AGActive, not recruitingCarcinoma, Non-Small-Cell Lung | Non-Small Cell Lung Cancer | Non Small Cell Lung Cancer | Nonsmall Cell Lung Cancer | Non-Small Cell Lung CarcinomaUnited States
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingStage IIIA Lung Non-Small Cell Cancer AJCC v7 | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage III Lung Non-Small Cell Cancer AJCC v7United States, Canada
-
Bristol-Myers SquibbActive, not recruitingNon-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Metastatic Non-small Cell Lung CancerAustralia, Russian Federation, United States, Argentina, Austria, Belgium, Brazil, Chile, France, Germany, Ireland, Italy, Mexico, Netherlands, Poland, Romania, Spain, Switzerland, United Kingdom
-
National Cancer Institute (NCI)University of Chicago; City of Hope Medical Center; University of Southern California and other collaboratorsCompleted
-
Hoffmann-La RocheRecruitingNon-small Cell Lung CancerKorea, Republic of, United States, Canada, Turkey, Brazil, Spain, France, Germany, Australia, Italy, Belgium, Mexico
-
Ascentage Pharma Group Inc.TerminatedSmall Cell Lung CancerUnited States, Australia
-
Trans Tasman Radiation Oncology GroupRecruitingMetastatic Non Small Cell Lung CancerAustralia, Singapore
-
Ascendis Pharma Oncology Division A/SRecruitingAdvanced Solid Tumor | Metastatic Solid Tumor | Platinum-resistant Ovarian Cancer | Locally Advanced Solid Tumor | Post Anti-PD-1 Melanoma | 2L+ Cervical Cancer | Neoadjuvant Melanoma | Neoadjuvant Non-Small Cell Lung Cancer | Post Anti-PD-(L)1 Non-Small Cell Lung Cancer | Post Anti-PD-(L)1 Small Cell...United States, Australia, Korea, Republic of
-
Eli Lilly and CompanyCompletedNon-small Cell Lung CancerUnited States, Argentina, China, Korea, Republic of
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedMetastatic Non-Small Cell Lung CancerUnited States
-
AEterna ZentarisCompletedNon Small Cell Lung CancerUnited States
-
AVEO Pharmaceuticals, Inc.Biodesix, Inc.TerminatedNon-small Cell Lung CancerKorea, Republic of, United States, Australia, Taiwan, Singapore, Hong Kong, Italy
-
Mirati Therapeutics Inc.RecruitingAdvanced Non-Small Cell Lung Cancer | Metastatic Non-Small Cell Lung CancerUnited States, Korea, Republic of, Italy, Spain, Czechia, Hungary, Netherlands, Canada, Australia, Austria, Belgium, Germany, Ireland, Israel, Poland, United Kingdom, Taiwan, Portugal
-
Medical University of South CarolinaRain Oncology IncTerminated
-
ImmunityBio, Inc.Active, not recruitingNon Small Cell Lung CancerUnited States
-
AstraZenecaCompletedNon-small Cell Lung CancerTurkey, Hong Kong, Australia, Egypt, India, Kuwait, United Arab Emirates
-
Genentech, Inc.CompletedNon-Squamous Non-Small Cell Lung CancerAustralia, United States, Hungary, France, Germany, Czech Republic, Poland
-
GlaxoSmithKlineCompletedNon-Small-Cell Lung CancerNetherlands, Finland, Taiwan, Belgium, Canada, Israel, Poland, Spain, Australia, Singapore, Latvia, Thailand, United Kingdom, Germany, Italy, China, Russian Federation, Philippines, Austria, Greece, Hungary, Denmark, France, Ukraine, Li... and more
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)RecruitingMelanoma | Renal Cell Carcinoma | NSCLC | SCLC | Breast Carcinoma | Non-small Cell Lung Cancer | Small-cell Lung Cancer | Brain Metastases, AdultUnited States
-
TakedaActive, not recruitingALK+ Advanced NSCLCSpain, China, Korea, Republic of, Taiwan, Hong Kong, Thailand, Italy, Romania, United States, Mexico, Croatia, Russian Federation, Argentina, Canada, Germany, France, Austria, Chile, Greece, Sweden
-
Medical University of South CarolinaTerminatedNonsquamous Nonsmall Cell Neoplasm of Lung | Nonsmall Cell Lung Cancer Stage IIIUnited States
-
Genzyme, a Sanofi CompanyCompletedLung Cancer | Non Small Cell Lung CancerUnited States, Australia, France, Italy, South Africa, Spain, United Kingdom, Sweden, Philippines, Germany, Hong Kong, Argentina, Israel, Portugal, Greece, Taiwan, Mexico, Belgium, Venezuela, Colombia, India
-
Eli Lilly and CompanyCompletedNon-Small Cell Lung CancerUnited States
-
Eli Lilly and CompanyBristol-Myers SquibbCompletedNon-small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung CancerUnited States
-
AmgenRecruitingExtensive Stage Small Cell Lung CancerKorea, Republic of, United States, Netherlands, Taiwan, Switzerland, Spain, Canada, Israel, Germany, France, Belgium, Australia, Japan, Italy, Denmark
-
Aeglea BiotherapeuticsMerck Sharp & Dohme LLCCompletedSmall-cell Lung CancerUnited States, Puerto Rico
-
SCRI Development Innovations, LLCCelgeneCompletedExtensive-Stage Small Cell Lung CancerUnited States
-
Gilead SciencesMerck Sharp & Dohme LLCActive, not recruitingNon-small Cell Lung CancerUnited States, Spain, Italy, France, Australia, Hong Kong, Korea, Republic of, Malaysia, Taiwan, Germany, United Kingdom, Canada
-
GlaxoSmithKlineCompletedLung Cancer, Non-Small Cell | Non-Small-Cell Lung CancerUnited States, Canada, Poland
-
Bristol-Myers SquibbCompletedSquamous Cell Non-small Cell Lung CancerUnited States, France, Chile, Australia, Netherlands, Argentina, Austria, Canada, Czechia, Germany, Hungary, Ireland, Italy, Mexico, Norway, Peru, Poland, Romania, Russian Federation, Spain, United Kingdom
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)CompletedLung Non-Squamous Non-Small Cell Carcinoma | Stage IV Lung Non-Small Cell Cancer AJCC v7 | EGFR Exon 19 Deletion Mutation | EGFR NP_005219.2:p.L858RUnited States
-
European Organisation for Research and Treatment...CompletedLung CancerSpain, Netherlands, Belgium, Egypt, South Africa, Germany, Switzerland, France, Poland, Italy, Czech Republic, Greece
-
Human Genome Sciences Inc.CompletedNon Small Cell Lung CancerUnited States, Germany, Hungary, Romania
-
National Cancer Institute (NCI)CompletedRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer AJCC v7 | Stage IIIB Non-Small Cell Lung Cancer AJCC v7United States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedLung CancerUnited States
-
Bristol-Myers SquibbCompletedNon-Small-Cell Lung CancerUnited States, Canada
-
Navire Pharma Inc., a BridgeBio companyBristol-Myers SquibbRecruitingSolid Tumor | Non Small Cell Lung CancerUnited States
-
AbbVieCompletedNon-squamous Non-small Cell Lung CancerUnited States, Argentina, Australia, Canada, Czechia, Denmark, Finland, Germany, Hungary, Israel, Japan, Korea, Republic of, Netherlands, New Zealand, Russian Federation, South Africa, Spain, Taiwan, Turkey, United Kingdom
-
Eli Lilly and CompanyUniversity of Colorado, Denver; PPD; Parexel; ICON Clinical Research; Laboratory... and other collaboratorsActive, not recruitingNon Small Cell Lung CancerUnited States, Belgium, Brazil, Russian Federation, Serbia, Spain, United Kingdom, Germany, Australia, Hungary, Italy, Romania, Austria, Croatia, France, Greece, Poland, Portugal, Slovakia, South Africa, Philippines, Canada, Korea,... and more